Nuvation Bio Inc. (NUVB)
1.77
-0.05 (-2.75%)
At close: Mar 31, 2025, 3:59 PM
Nuvation Bio Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 7.87M | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 7.08M | 222K | 484K | 368K | 103K | n/a | n/a |
| Gross Profit | 795K | -222K | -484K | -368K | -103K | n/a | n/a |
| Operating Income | -592.63M | -99.82M | -119.73M | -93.32M | -43.55M | -32.1M | -992K |
| Interest Income | 27.06M | 24.61M | 7.45M | 2.96M | 1.95M | 1.37K | n/a |
| Pretax Income | -567.94M | -75.8M | -104.2M | -86.85M | -41.66M | -33.55M | -992K |
| Net Income | -567.94M | -75.8M | -88.66M | -79.73M | -39.5M | -33.55M | -992K |
| Selling & General & Admin | 69.23M | 28.53M | 31.92M | 24.28M | 10.95M | 6.99M | 509.33K |
| Research & Development | 99.12M | 71.29M | 87.81M | 69.04M | 32.6M | 25.11M | 482.67K |
| Other Expenses | 425.07M | n/a | -872K | -644K | -271K | n/a | n/a |
| Operating Expenses | 593.42M | 99.82M | 119.73M | 93.32M | 43.55M | 32.18M | 992K |
| Interest Expense | 341K | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | 1.7M | n/a | n/a | n/a | 400.00 | n/a |
| Cost & Expenses | 600.5M | 99.82M | 119.73M | 93.32M | 43.55M | 32.18M | 992K |
| Income Tax | n/a | n/a | -15.54M | -7.11M | -2.16M | n/a | n/a |
| Shares Outstanding (Basic) | 268.77M | 218.88M | 216.72M | 197.89M | 97.53M | 206.67M | 80.99M |
| Shares Outstanding (Diluted) | 268.77M | 218.88M | 216.72M | 197.89M | 97.53M | 206.67M | 80.99M |
| EPS (Basic) | -2.11 | -0.35 | -0.41 | -0.4 | -0.4 | -0.16 | -0.01 |
| EPS (Diluted) | -2.11 | -0.35 | -0.41 | -0.4 | -0.4 | -0.16 | -0.01 |
| EBITDA | -566.91M | -99.6M | -119.53M | -89.35M | -43.45M | -32.09M | n/a |
| Depreciation & Amortization | 683K | 222K | 484K | 368K | 103K | 13K | 992K |